ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by AI stocks. The ...

Persistent leaks” and “unaddressed contamination issues” are among the problems workers say they witnessed at one of the ...

The latest trading session saw Abbott (ABT) ending at $124.50, denoting a -2% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 3.46%. Meanwhile, the ...

Under this category, M/S Abbott Asia Investments Limited dominates with 76.26 million shares. Local General Public grabs the ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Global healthcare company Abbott launched the 12th Green Ribbon Action on Friday to advocate for better care of the digestive ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions. Three Motley Fool contr ...

Abbott Laboratories (NYSE:ABT) is an Illinois-based medical device company that provides services and products in diagnostics, nutrition, and established pharmaceuticals. In the fourth quarter of ...

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in ...